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Embryonic facial development in chick embryos involves a sequential activation of genes that control differential growth
and patterning of the beak. In the present study we isolate one such gene, the transcription factor, AP-2, that is known to
be expressed in the face of mouse embryos. The protein sequence of chick AP-2a is 94% homologous to human and mouse
AP-2. Wholemount in situ hybridization with a probe for chick AP-2 identi®es expression from primitive streak stages up
to stage 28. The most striking expression patterns in the head are during neural crest cell migration when AP-2 transcripts
follow closely the tracts previously mapped for neural crest cells. Later, expression in the facial mesenchyme is strongest
in the frontonasal mass and lateral nasal prominences and is downregulated in the maxillary and mandibular prominences.
Once limb buds are visible, high expression is seen in the distal mesenchyme but not in the apical ectodermal ridge. The
expression patterns of AP-2 in stage 20 embryos suggested that the gene may be important in ``budding out'' of facial
prominences and limb buds. We implanted beads soaked in retinoic acid in the right nasal pit of stage 20 embryos resulting
in a speci®c inhibition of outgrowth of the frontonasal mass and lateral nasal prominences. AP-2 expression was completely
down-regulated in the lateral nasal within 8 hr of bead application. In addition, the normal up-regulation of AP-2 in the
frontonasal mass did not occur following retinoic-acid treatment. There was an increase in programmed cell death around
the right nasal pit that accompanied the down-regulation of AP-2. Prominences whose morphogenesis were not affected
by retinoic acid did not have altered expression patterns. We removed the apical ectodermal ridge in stage 20 limb buds
and found that AP-2 expression was partially downregulated 4 hr following ridge removal and completely downregulated
8 hr following stripping. Application of an FGF-4 soaked bead to the apex of the limb bud maintained AP-2 expression.
Thus AP-2 is involved in outgrowth and could be regulated by factors such as FGFs that are present in the ectoderm of
both the face and limb. q 1997 Academic Press
INTRODUCTION AP-2 can bind to the promoter of approximately 100
genes via a conserved palindromic sequence (5*-GCCN3-
One of the great challenges in developmental biology is GGC-3*; Mitchell et al., 1987; Mitchell and Tjian, 1989;
to understand the control of patterning in the embryo. It is Williams and Tjian, 1991). Isolation of the mouse AP-2
likely that some conserved regulatory pathways are de- genes and analysis of highly localized expression patterns
ployed at several different stages of development and at in embryos raised the possibility that AP-2 is important
several different sites. One example of this may be in cranio- for certain aspects of embryogenesis (Mitchell et al.,
facial and limb development where several molecules have 1991; Chazaud et al., 1996). In particular, expression of
been identi®ed that are expressed in both locations. One AP-2 transcripts in the cranial neural crest, facial promi-
such molecule is the transcription factor activating protein- nences, and limb buds suggested that AP-2 could be an
important regulatory gene for face and limb develop-2 (AP-2).
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ment. Indeed, knockout mice lacking functional AP-2 tween outgrowth and maintenance of expression of AP-
2 in the facial prominences and wing bud. Chick embryosprotein have severe dismorphology of the face and phoco-
melic forelimbs (Schorle et al., 1996; Zhang et al., 1996). exposed to retinoic acid have truncations of the frontona-
sal mass and develop clefts of the beak (Tamarin et al.,In order to further study the function of AP-2 in face and
limb development we turned to the chick model system 1984; Wedden and Tickle, 1986; Richman and Leon Del-
gado, 1995). There is a lag of about 24 hr before the ®rstwhich offers several assays for studying gene function in
manipulated embryos. changes in shape of the upper beak prominences can be
detected thus early changes in gene expression can beThe chick face is formed during four critical periods
of embryonic development: (1) cranial neural crest cell studied in this time window. The molecular causes of
the failure in outgrowth of the frontonasal mass are notformation [3 somites, stage 80 (Hamburger and Hamil-
ton, 1951)] neural crest cell movement (3±17 somites, clear but one possibility is that AP-2 expression is altered
which in turn modi®es expression of factors importantstages 80 to 12), (3) proliferation of facial mesenchyme
(stages 15 to 24), and (4) fusion and differentiation of the for facial growth. The present study examines the expres-
sion of AP-2 following treatment of the chick face withfacial prominences (swellings of mesenchyme covered in
epithelium which surround the primitive oral cavity; retinoic acid and links the process of outgrowth of the
facial prominences with decrease in AP-2 expression andstages 28 to 30). The cranial neural crest moves away
from the posterior forebrain, midbrain, and anterior hind- a concomitant increase in programmed cell death. In a
related experiment, we remove the apical ectodermalbrain in an antero-posterior wave starting at 3 somites
(Lumsden et al., 1991; Couly and Le Douarin, 1993). The ridge and study the expression of AP-2 at de®ned inter-
vals following ridge removal. Our results on both thecells move from the dorsal mesencephalon ventral into
the upper face, skirting the eyes (Johnston, 1966; Lums- face and limb demonstrate that AP-2 expression is down-
regulated if outgrowth is inhibited.den et al., 1991). Cells from the posterior mesencephalon
and anterior rhombencephalon move into the ®rst
branchial arch, ending by stage 15 (Lumsden et al., 1991;
Kontges and Lumsden, 1996). MATERIALS AND METHODS
Few genes are known to be expressed in cranial regions
of the migrating neural crest, anterior to rhombomere 2 Animals
(Hoxa-2 is the most anteriorly expressed homeobox gene;
Fertile white leghorn chicken eggs were purchased from Coast-Prince and Lumsden, 1994) and these are members of the
line Chicks (Abbotsford, B.C.) and incubated at 387C until the de-
muscle-speci®c homeobox family (Msx-1; Lyons et al., sired stage was reached. Embryos were staged according to the crite-
1992), RXR-g (retinoid X receptor-g; Rowe and Brickell, ria of Hamburger and Hamilton (1951).
1995), and Slug, a zinc ®nger transcription factor (Nieto
et al., 1994). Therefore it is important to study AP-2
Cloning of AP-2which is expressed in murine forebrain- and midbrain-
derived neural crest cells and subsequently in facial
A stage 24 chick head cDNA library was synthesized in Lambda
prominences (Mitchell et al., 1991 Chazaud et al., 1996) Zap-II (Stratagene) and screened with a 240-bp mouse cDNA
The developing facial prominences and limb buds both (Mitchell et al., 1991). The primary screen resulted in 3 positive
arise from buds of mesenchyme encased in epithelium. clones, all with a 1858-bp insert. One of the clones, 1.1, was grown
The limb bud mesoderm is derived from lateral plate up and sequenced using the Sanger method. The sequencing was
partly carried out by the Dept. of Molecular Biology, Simon Frasermesoderm and buds out from the body wall starting at
University. Sequence analysis was performed with the BLASTstage 17 under the in¯uence of ectodermal signals, proba-
program. A subclone of the gene removing 600 bp of 3* sequencebly members of the ®broblast growth factor family (Cohn
(cut at the StyI site) was generated for use in expression studieset al., 1995; Crossley et al., 1996; Vogel et al., 1996).
(Fig. 2A).Later, once the limb bud is established, the apical ecto-
dermal ridge (AER) is responsible for maintaining out-
growth of the limb (Saunders, 1948; Summerbell, 1974). Southern and Northern Blotting
Facial prominences also require ectoderm for outgrowth
Genomic DNA was isolated from chick embryos and digested(Wedden, 1987; Saber et al., 1989; Richman and Tickle,
with EcoRI, HindIII, PstI, or BamHI. The gel was transferred to1989), although there are no obvious ridges similar to
supported nitrocellulose membrane (MSI) and probed with [32P]-the AER in facial ectoderm (Wedden et al., 1988). Facial
dCTP-labeled, 1.3-kb StyI fragment of the chick cDNA. Followingectoderm can support outgrowth and digit formation in
hybridization, the blot was washed to a maximum stringency of
limb bud mesenchyme (Richman and Tickle, 1992), sug- 0.11 SSC, 0.5% SDS, 557C for 10 min, twice, and exposed to ®lm
gesting that some signals passing between epithelium overnight.
and mesenchyme are similar in these two parts of the Stage 24 frontonasal mass facial prominences were dissected in-
embryo. cluding all tissue between the nasal pits (Richman and Crosby,
1990). Total RNA was isolated according to the method of Chomc-Our present study investigates the relationship be-
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zinski and Saachi (1987) and 20 mg was separated on a 1% agarose/ dark ®eld or bright ®eld illumination. Embryos were re®xed in
10% buffered formalin and selected specimens were embeddedMops-formaldehyde gel. The gel was blotted onto supported nitro-
cellulose (MSI). To generate probes, inserts from AP-2 were gel in wax and sectioned at 10 to 12 mm to visualize tissue localiza-
tion of the probe. In some instances sections were counterpuri®ed and labeled with [32P]dCTP using a random prime kit (Phar-
macia). The blots were hybridized overnight at 427C in 50% for- stained with 0.1% Malachite green. Sections were photographed
with a Zeiss compound microscope.mamide and washed to a maximum stringency of 0.11 SSC, 657C,
15 min, prior to exposure to X-ray ®lm for 2 days.
In Situ Hybridization on Sections
Embryo Manipulations
Embryos were ®xed in 4% paraformaldehyde/PBS, processed
Bead implantation in the nasal pit. AG1X-2 beads, 100 mm in through ethanols, and embedded in wax. The AP-2 probe used was
diameter (formate form, Bio-Rad) were soaked in 5 mg/ml of all- the StyI fragment described above. Another probe generated from
trans-retinoic acid dissolved in dimethylsulfoxide (DMSO) and a 231-bp fragment (nucleotides 939±1170) located in the DNA bind-
rinsed in medium with 10% fetal calf serum (Gibco) as described ing/dimerization domain, did not show speci®c hybridization pat-
in Richman and Leon Delgado (1995). Beads were implanted into terns. The methods used for preparing [35S-UTP]-labeled probe and
the right nasal pit of stage 20 embryos and they were incubated 4, hybridization were identical to those described in Rowe et al. (1991)
8, 16, 24, or 48 hr prior to ®xation. Control embryos were treated and Richman and Delgado (1995).
with DMSO-soaked beads.
AER removal and FGF-4 bead implantation. Stage 20 embryos
were used for these experiments. The apical ectodermal ridge Detection of Programmed Cell Death
(AER) was stained with neutral red, carefully elevated with a
®ne tungsten needle, and then excised. In some cases a bead We used the TUNEL method (terminal deoxynucleotide trans-
soaked in 1 mg/ml FGF-4 (Genetics Institute) was stapled to the ferase [TdT]-mediated dUTP-digoxygenin nick-end-labeling) to
apex of the stripped wing using platinum wire. Embryos were detect programmed cell death in sections and in wholemounts.
incubated a further 4, 6, 8, 12, and 24 hr and then ®xed for whole- For TUNEL on sections, the methods of Wride et al. (1994) were
mount in situ hybridization. used. Embryos were ®xed in 4% paraformaldehyde/PBS, embed-
ded in wax, and sections from normal and retinoic acid treated
embryos were placed on slides together. Following dewaxing and
Wholemount Immunocytochemistry with the AP-2 rehydrating slides were incubated in 21 SSC (0.3 M NaCl, 30
Antibody mM sodium citrate, pH 7) at 607C for 15 min, treated with 20
mg/ml proteinase K at room temperature for 15 min, re®xed inProcedures as described in Zhang et al. (1996) and Mark et al.
4% paraformaldehyde/PBS for 20 min, rinsed, and then incu-(1993) were used. Brie¯y, the monoclonal antibody 3B5, which rec-
bated in the terminal deoxytransferase buffer (140 mM sodiumognizes an AP-2a-speci®c epitope in the mouse (Zhang et al., 1996),
cacodylate, 1 mM cobalt chloride, 30 mM Tris±HCl, pH 7.2) forwas also utilized for the chicken studies. Embryos were ®xed in
5 min. Terminal deoxytransferase (0.3 U/ml and digoxygenin-4% paraformaldehyde in phosphate-buffered saline and then incu-
labeled dUTP (10 mM, Boehringer Mannheim) were added to thebated in 0.1% hydrogen peroxide, 1% Triton X-100, 10% fetal calf
buffer and this solution was added to the sections. A coverslipserum in PBS overnight at 47C to inactivate endogenous peroxi-
was placed overtop and the slides were incubated at 377C fordases. Embryos were incubated in the supernatant for 3 days at 47C
1.5 hr. Negative control sections did not have the enzyme andand presence of antibody was detected with a peroxidase-conju-
positive control sections were pretreated with DNAse I (0.06 U/gated anti-mouse IgG.
ml). The DNAse I buffer consisted of 40 mM Tris±HCl, pH 7.5,
6 mM magnesium chloride, and 0.1 mM dithiothreitol. Detec-
tion of the label was achieved by incubating the slides with anWholemount in Situ Hybridization
anti-digoxygenin antibody conjugated to alkaline phosphatase
(Boehringer Mannheim) at 47C overnight followed by incubationThe methods of IzpisuÂ a-Belmonte et al. (1993), Hemmati-Bri-
vanlou and Harland (1990), and Henrique and Ish-Horowitz (per- in substrate for alkaline phosphatase (BCIP and NBT). Slides
were coverslipped and photographed under bright®eld illumina-sonal communication, C. D. Stern) were used for these experi-
ments. Embryos were ®xed in 4% formaldehyde in PBS, 2 mM tion.
Wholemount TUNEL methods were based on those of ConlonEGTA overnight, processed into 100% methanol, and stored at
0207C until use. Embryos stage 10 and younger were treated for et al. (1995). Embryos were ®xed in 4% paraformaldehyde/PBS
overnight, dehydrated in a series of methanol/PBS solutions, andup to 10 min in 10 mg/ml of proteinase K. Embryos stage 12±18
were treated for 25 min in 10 mg/ml proteinase K. Stages 20, 24, stored at 0207C in 100% methanol. Embryos were rehydrated
to PTW (PBS with 0.1% Tween 20), treated with proteinase Kand 28 embryos were treated for 15, 20, and 25 min, respectively,
with 20 mg/ml proteinase K. Hybridization was carried out with (20 mg/ml) 20 min at room temperature, re®xed in 0.2% gluteral-
dehyde and 4% paraformaldehyde in PTW, incubated in 0.1%0.5 mg/ml digoxygenin-labeled probe, 50% formamide, 1.31 SSC
(pH 4.5), 50 mg/ml yeast RNA, 0.2% Tween 20, 0.5% Chaps, sodium borohydrate for 20 min at room temperature, washed in
TdT buffer (as described for sections) for 5 min, and incubated100 mg/ml heparin at 707C for 18 hr. High stringency washing
conditions were used to a maximum of 0.651 SSC/0.25% Chaps/ in TdT buffer containing 20 mM dig-dUTP and 0.3 U/ml TdT for
2 hr at 377C. Embryos were incubated in TBST (140 mM NaCl,25% formamide at 707C. Following detection with the DIG anti-
body (Boehringer Mannheim) embryos were photographed with 2.7 mM KCl, 25 mM Tris±HCl, 0.1% Tween 20) at 707C for 20
min, to inactivate endogenous alkaline phosphatases, and thena Leica dissection microscope using Fuji color print ®lm and
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FIG. 1. Comparison of the amino acid sequence chick AP-2 to those of human, mouse, and Xenopus. The Xenopus AP-2 is shown from
the sixth amino acid. Dashes were introduced to preserve sequence overlap. Amino acid sequence variation is indicated by l. Similar
amino acids are indicated by asterisks (*). Translation stop codons are represented by boxes (j).
antibody detection as described in the wholemount in situs was teins, respectively (Winning et al., 1991; Fig. 1). We there-
carried out. fore concluded that we had isolated the chick AP-2a cDNA.
The region of highest homology (99%) is that spanning the
DNA binding and dimerization domains (aa 200 to 437). In
RESULTS contrast, there is more variation in the region spanning
amino acids 20 to 200 (87% conserved), a region that harbors
Cloning and the Primary Structure of Chick AP-2a the transactivation domain (Williams and Tjian, 1991);
however, most of the proline and glutamine residues in thisA cDNA clone for chick AP-2a was isolated containing
area are located at identical positions. The predicted proteina predicted open reading frame of 437 amino acids that is
has a molecular weight of 48 kDa, very similar to the size94% conserved relative to human and mouse AP-2a (Wil-
liamson et al., 1996) and 92% homologous to xenopus pro- determined for human AP-2a (Williams et al., 1988).
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lated region; these, if any exist, are likely to be further
upstream.
Southern analysis of genomic DNA using the same
probe as in the Northern blot and moderately stringent
washing conditions, identi®ed one large fragment of
about 40 kb in EcoRI-digested DNA (Fig. 2B), indicating
a single copy of the chick AP-2 gene in the genome. How-
ever, some fragments with faint intensity were also ob-
served in this lane, suggesting more AP-2 genes with less
sequence homology may exist in the chick genome. We
expect that our probe will recognize other AP-2 genes
(Moser et al., 1995; Williamson et al., 1996) in addition
to AP-2a, if these exist in the chicken.
Expression of AP-2 in Early Gastrulating Embryos
A minimum of 3 embryos were examined for each devel-
opmental stage. In stage 5 embryos AP-2 transcripts were
localized to the anterior and lateral epiblast but not in the
hypoblast, presumptive neural plate, primitive streak,
Hensen's node, or the forming mesoderm (Figs. 3B and 3C).
In 3±4 somite embryos (stage 80) expression was restricted
to the ectoderm lateral and anterior to the neural plate in
the subcephalic pocket (Figs. 3E±3G). AP-2 protein was ex-
pressed in the same pattern as the RNA transcripts (Figs.
3A and 3D).
FIG. 2. (A) Schematic representation of AP-2 cDNA clone. Box AP-2 Is Expressed in Presumptive Premigratory
represents AP-2 coding region: shaded area, the transactivation do- and Migratory Neural Crest Cells
main; hatched area, the DNA binding and dimerization domains.
In 5±8 somite embryos (stage 8/) there was expressionStyI site was used for the hybridization probe. The probe is repre-
of AP-2 at the dorsal edges of the neural folds in thesented by an arrow. (B) Southern analysis of chick genome. Restric-
tion enzymes used are indicated on top of each lane: E (EcoRI), H cranial region down to the 4th or 5th somite and in the
(HindIII), P (PstI), and B (BamHI). lateral ectoderm of the tail region (data not shown). It
was not possible to detect expression lateral to the neural
folds and in the mesoderm until later stages. In stage 10
embryos (10 somites, Fig. 4A), AP-2 transcripts were seen
in a diffuse group of cells ¯anking the neural tube, ex-
The nucleotide sequence of the chick AP-2a coding tending from the posterior diencephalon down to and in-
region is 84, 83, and 78% identical to human, mouse and cluding the second rhombomere (r2). Sections of these
Xenopus AP-2a DNA, respectively. Our chicken clone is embryos revealed expression in the mesenchyme as well
not similar to the variants of mouse AP-2a that have as surface ectoderm and in the dorsal midline of the neu-
been identi®ed (Meier et al., 1995). The cDNA clone con- ral tube (not shown). In the rhombencephalon there were
tains 91 base pairs of 5* untranslated sequence and there two regions with lower expression of AP-2 and these co-
are two possible start sites for protein translation. The incided with r3 and r5 (Fig. 4A). There was expression
3* untranslated sequence consists of 453 base pairs (Gen- caudal to the hindbrain in the dorsal midline of the neu-
Bank Accession No. U72992). ral tube tapering off by the 6th somite. In stage 12 em-
The expression of AP-2 was examined by Northern blot bryos the pattern of AP-2 transcripts was more de®ned
analysis of total RNA from stage 24 chicks using the 1.3- (Figs. 4B and 4D±4F). AP-2 expressing cells were lateral
kb StyI fragment (Fig. 2A) as the probe. A major band of to, but did not lie directly over the dorsal midline of the
4.3 kb was detected (data not shown), a larger transcript mesencephalon. There were AP-2 expressing cells along
than those reported for human, mouse, and Xenopus (3.3± the midline of the hindbrain extending from region of r2
3.6, 1.8 to 3, and 1.8 to 2.6, respectively; Williams et al., to r8 (Fig. 4B). In addition, there were two streams of AP-
1988; Moser et al., 1993; Winning et al., 1991). The 1.9- 2 expressing cells emanating from r4 and r6 and there
kb cDNA clone we isolated is probably not full-length. were no AP-2 expressing cells adjacent to r3 and r5 (Fig.
4B). Sections of the embryo in Fig. 4B reveal that expres-There are no hairpin or direct repeats in the 5* untrans-
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FIG. 3. Expression of AP-2 in gastrulating and early neurula stage embryos by in situ hybridization with AP-2 anti-sense probe or by an
antibody to human AP-2. Approximate planes for sections in C, F, and G are shown in A and D with horizontal or vertical lines. Scale
bar, 500 mm in A, B, D, E; 100 mm in C, F, and G. Key: (e) ectoderm, (h) hypoblast, (hn) hensen's node, (m) mesoderm, (np) neural plate,
(scp) subcephalic pocket. (A) Stage 4 embryo showing AP-2 protein expression in a horseshoe shape surrounding the presumptive neural
plate. (B) Expression of RNA in a stage 5 embryo anterior and lateral to the presumptive neural plate, not extended as far caudal as in A.
(C) Transverse section through the embryo in A. High expression in the epiblast, no expression in the mesoderm or hypoblast. (D) Stage
8 embryo shows AP-2 protein is expressed lateral to the neural plate. (E) In stage 8 embryos (3 somites) there is high expression of AP-2
transcripts at the junction of the ectoderm and neural plate (arrowheads) and no expression in the greater area of the neural plate similar
to the protein pattern in D. (F) Parasagittal section of stage 8 embryo showing expression in the neural ectoderm and in the subcephalic
pocket. (G) Transverse section shows expression in the surface ectoderm lateral to the neural plate.
sion of AP-2 was present in the mesenchyme surrounding 4D and 4E). In addition there was strong expression in
the lateral surface ectoderm and no expression in thethe eye primordia, in the ectoderm that will form the
lens and in the presumptive branchial arch region (Figs. neural epithelium of the brain (Figs. 4D and 4E). The
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FIG. 4. AP-2 expression in presumptive premigratory and migratory neural crest cells. Approximate planes for sections in D, E, and F
are shown in B with horizontal lines. Scale bar, 500 mm in A, B, and C; 100 mm in D, E, and F. Key: (bm) branchial arch mesenchyme;
(e) eye, (m) mesenchyme, (nc) presumptive neural crest cells, (op) otic placode, (r3, r4, or r5) rhombomere 3, 4, or 5, (st) stage. (A) Stage
10 embryo. Expression at the dorsal midline of the neural tube and lateral to the neural tube. (B) Stage 12 embryo. Expression ¯anking
the mesencephalon, the dorsal midline of the hindbrain, and streams of AP-2 expressing cells adjacent to r4 and r6. (C) Stage 12 embryo.
AP-2 antibody staining shows the protein is expressed in the same pattern as the RNA including along the dorsal midline of the neural
tube in the hindbrain (arrowhead). (D) Stage 12, transverse section through the embryo in B. Expression in mesenchyme and surface
ectoderm that will form the lens (arrowheads). (E) Stage 12, transverse section through the presumptive branchial arch region. Expression
in mesenchyme and ectoderm (arrowheads). (F) Stage 12, transverse section through the otic placodes at the level of r5. Expression at the
dorsal edges of neural folds (arrowheads).
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section through the otic placode (Fig. 4F) showed strong the mandibular mesenchyme, except in the anterior mid-
line (Fig. 6E).AP-2 signal at the dorsal edges of the neural tube, but no
expression in the mesenchyme or ectoderm lateral to the
neural tube. In the presumptive tail, AP-2 expression was
AP-2 Is Down-Regulated in the Frontonasal Massfound at the lateral edges of the ectoderm covering the
and Lateral Nasal Prominence in Retinoic-Acidunsegmented mesoderm (data not shown). AP-2 antibody
Treated Embryosstaining in a stage 12 embryo overlapped the pattern of
RNA transcripts (Fig. 4C). The mechanism for retinoic acid-induced facial clefts
may involve changes in expression of AP-2. In embryos
treated with beads soaked in 5 mg/ml of retinoic acid
AP-2 Is Expressed in the Craniofacial Region placed in the right nasal pit, expression was signi®cantly
during Important Stages of Face Development down-regulated in the lateral nasal prominence within 8
hr (Compare Fig. 6A with 6B; N  3) and completelyOnce the embryo has turned (stage 13), expression was
visible in 2 streams of cells skirting the otic vesicle and down-regulated in the lateral nasal prominence within
16 hr (Fig. 6D; N  4). The morphology of the face wasin the proximal mesenchyme of the ®rst branchial arch
(Fig. 5A and data not shown). Between stages 17 and 20 severely affected 48 hr after bead implantation such that
the corners of the frontonasal mass were pinched and thethere was also expression above background levels in the
ventral mesenchyme of the upper face between the nasal right nasal pit was nearly obliterated (Fig. 6F). However,
the two expression domains in the maxillary promi-pits, in the 1st, 2nd, 3rd, and 4th branchial arches and
in the trigeminal ganglion (Figs. 5B and 6A and data not nences remained unchanged in retinoid-treated embryos
(compare Fig. 6E with 6F). The frontonasal mass normallyshown). AP-2 transcripts were present in the surface ec-
toderm of the head, but not in the nasal placodes (Fig. has increased AP-2 expression at stage 24, however in
retinoic acid treated embryos this increase does not occur5B and data not shown). Sections of the branchial arches
revealed higher levels of AP-2 transcripts in the periph- (compare Fig. 6C and D).
eral mesenchyme than in the mesodermally derived core
(not shown). In more caudal regions, expression of AP-2
Programmed Cell Death in Retinoic Acid-Treatedtranscripts was noted in the anterior half of each somite
Embryoscoincident with sites of motor axon outgrowth (Figs. 8A,
8D, and 8E; Keynes and Stern, 1984). We examined retinoic acid-treated and nontreated em-
bryos for cells undergoing programmed cell death. Non-At stage 24 the level of AP-2 transcripts increased in
the mesenchyme and ectoderm across the frontonasal treated embryos exhibited several localized regions of in-
creased program cell death including the junction of themass and lateral nasal prominences (Figs. 5C, 5D, 6C,
and 6E). The maxillary prominences AP-2 expression lateral nasal and maxillary prominences, the midline and
caudal edge of the mandibular prominence, and the tri-was restricted to two patches, an intense lateral region
and a less intense area in the medial and caudal aspect geminal ganglia (Figs. 7A±7C and data not shown). The
retinoic acid-treated embryos had localized increase inof the maxilla (Figs. 5C, 6C, 6E, and 8A). The expression
in the mandibular prominence decreased from stage 20 cell death on the side where the bead was placed ex-
tending across the caudal edge of the frontonasal massonwards and by stage 24 expression was limited to the
auricular hillock that will give rise to the external ear (Figs. 7A and 7B). Sections of retinoic acid-treated em-
bryos 24 and 48 hr after retinoic acid beads were im-and a patch of mesenchyme about 500 mm away from
the midline on the stomodeal side of the prominence planted, revealed a small proportion of mesenchymal
cells and a localized region of ectoderm had increased(Figs. 5C, 6C, and 8A and data not shown). In the 2nd
branchial arch expression was restricted to the caudal cell death (Fig. 7D and data not shown).
border (Figs. 5C and 8A). There is a gradient of expression
of AP-2 in the in two lateral stripes along the hindbrain
Expression of AP-2 in the Limb Buds Is Associatedranging from very weak signal in r1 and r2 to strong
with Distal Outgrowthsignal in more caudal rhombomeres (Fig. 5C and data not
shown). Expression was also noted in the junction of the The ®rst stage at which AP-2 expression could be de-
tected in the limb buds was stage 17±18. During earlymesencephalon and diencephalon (data not shown).
At stage 28 transcripts were concentrated along the budding stages of limb formation, both the wing and leg
buds expressed high levels of AP-2 in the distal mesen-caudal edge of the frontonasal mass and medial side of
the lateral nasal prominences (Figs. 5D and 6E). In the chyme (Figs. 8D and 8E, left wing bud, and data not
shown). In addition, sections of the wholemount in situmaxillary prominence there was strong expression in the
medial and caudal part of the prominence as well as the embryos revealed that the dorsal and ventral ectoderm
express AP-2 but not the AER (data not shown). By stagelateral region that will form the lateral aspects of the
upper beak (Fig. 6E). There was minimal expression in 24 expression was not restricted to the distal mesen-
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FIG. 5. AP-2 expression in the craniofacial region during face development. All panels photographed with dark-®eld illumination.
C and D used radiolabeled probes on sectioned embryos. Scale bar, 1 mm in A and B; 0.5 mm in C and D. Key: (e) eye, (fnm)
frontonasal mass, (ln) lateral nasal prominence, (mx) maxillary prominence, (md) mandibular prominence, (np) nasal pit, (op) otic
pit, (tg) trigeminal ganglion, (2, 3) 2nd and 3rd branchial arch. (A) Stage 14. Expression skirts the otic vesicle and a stream of
expressing cells is just entering the ®rst branchial arch. There is also expression in the two streams of cells exiting r4 and r6. (B)
Stage 20. Expression in the trigeminal ganglion, caudal edge of the maxilla, lateral nasal prominence, and the 2nd and 3rd branchial
arches. There is lower expression in the nasal pit and in the mandibular prominence. (C) Stage 24, parasagittal section. Expression
is present in the lateral nasal prominence, the caudal edge of the maxilla, second branchial arch, the rhombencephalon, and the
surface ectoderm. (D) Stage 28, frontal section. Expression across the frontonasal mass in a chevron shape (arrowheads) and the
medial side of the lateral nasal prominences.
chyme but also spread along the anterior margin of the In order to see whether AP-2 is involved in limb out-
growth we stripped the AER of stage 20 limbs and exam-wing and leg buds (Figs. 8A±8C). A patch of cells in the
proximal ventral surface expressed high levels of AP-2 ined gene expression at de®ned intervals following ridge
removal. AER removal is known to truncate limb out-at stage 24 and stage 28 leg buds (Fig. 8B and data not
shown). growth. We observed a rapid, partial, down-regulation of
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AP-2 gene expression 4 hr following ridge removal (Fig. stages of neurulation, AP-2 is not completely restricted
to premigratory neural crest cells.8D); however, 2 hr later there was nearly complete loss
of gene expression in limb bud mesenchyme (Fig. 8E).
AP-2 transcripts were not present in limb mesenchyme
AP-2 Is a Marker for Migratory Cranial Neural8 hr or more following ridge removal (Figs. 8F and 8G).
Crest CellsIt is known that FGF-4 can replace the AER and stimu-
late the formation of distal cartilage elements (Nis- AP-2 is a very good marker for migratory neural crest
and cranial neural crest derivatives. Once neural tubewander et al., 1993). The application of an FGF-4 soaked-
bead to the apex of a stripped limb bud encouraged the closure has occurred AP-2 expression is closely corre-
lated with sites of cranial neural crest cell migration asformation of the radius and ulna in every case, whereas
untreated limb buds only form the most proximal part of detected with HNK-1 antibodies (Babich and Richman,
unpublished data) and as mapped with DiI (Lumsden etthe humerus (Wilke and Richman, unpublished data). We
found that similar to the AER, FGF-4 maintained AP-2 al., 1991), [3H]-TdR (Noden, 1975), and in quail-chick chi-
meras (LeLieÁ vre, 1978; Noden, 1978). The crest-free re-expression in the distal limb mesenchyme (Fig. 8C).
gions adjacent to r3 and r5 are also negative for AP-2
expression. We did note that there is expression of AP-2
in the dorsal midline of r3 and r5, but no AP-2 expressingDISCUSSION
cells are seen adjacent to the rhombomeres. This corre-
lates well with the in vitro observations that r3 and r5The AP-2 Gene Family
have the potential to give rise to neural crest cells (Gra-
There are now three members of the AP-2 gene family, ham et al., 1993). There is evidence showing that r3 and
AP-2a, AP-2b, and AP-2g (Moser et al., 1995; Chazaud r5 neural crest are undergoing increased programmed cell
et al., 1996; Oulad-Abdelghani et al., 1996; Williamson et death (Graham et al., 1994, 1993) and that a portion of
al., 1996), and these have been mapped to three separate the neural crest cells originating in r3 and r5 move in a
chromosomes in human and mouse. The expanding gene cranial or caudal direction and exit through r2 and r4
family and the fact that several splicing variants have (Sechrist et al., 1994). Our data shows that AP-2 is ex-
been identi®ed in the mouse (Meier et al., 1995) and hu- pressed in neural crest derived from r3 and r5; however,
man (Buettner et al., 1993) offer opportunities for various AP-2 transcripts are associated with vital cells, not dying
AP-2 proteins to dimerize in vivo (Williams and Tjian, cells. In the transgenic AP-2a 0/0 mice, the absence of
1991a, 1991b; Bosher et al., 1996). We have cloned AP- AP-2a protein is associated with increased cell death in
2a from the chicken but it is likely that other genes and the neural crest (Schorle et al., 1996). Thus AP-2 may be
isoforms of AP-2 exist in the chicken. Our probe would a marker for the proportion of r3 and r5 neural crest cells
recognize all forms of chicken AP-2a since it spans the that remain vital. It would be necessary to labeling r3 or
highly conserved DNA binding and dimerization do- r5 neural crest cells with DiI and then carry out in situ
mains. In the mouse there are differences in expression hybridization with the AP-2 probe in order to determine
between the AP-2a, AP-2b, and AP-2g/AP-2.2 mRNAs whether this was true.
(Moser et al., 1995, 1997; Chazaud et al., 1996). It is
therefore likely that chicken AP-2a is expressed in a sub-
AP-2 Expression Is High in Structures Derivedset of cells and tissues that we have detected with our in
from Cranial Neural Crestsitu hybridization probe.
AP-2 expression continues to be high in facial mesen-
chyme that will ultimately form the skeletal tissues. TheAP-2 Expression and Origin of Surface Ectoderm
mesenchymal tissue in the frontonasal region is derivedand Ectodermally Derived Structures
from an intermingling of cranial neural crest cells and meso-
derm originating in the somitomeres while in the branchialThe in situ hybridization studies show that there is a
correspondence between the horse shoe-shaped part of arches the mesodermal and ectomesenchymal cells segre-
gate and the central core is derived from the somitomeresthe epiblast that expresses AP-2 and that which gives rise
to the surface ectoderm, as well as the cranial ganglia (Trainor and Tam, 1995). It is interesting to note that AP-
2 expression is homogenous in frontonasal and lateral nasal(Rosenquist, 1966; Hatada and Stern, 1994). AP-2 contin-
ues to be expressed in the lateral ectoderm adjacent to prominence mesenchyme but in the branchial arches ex-
pression is highest in the periphery corresponding to theneural plate but not in the neural plate itself similar to
the mouse (Mitchell et al., 1991; Chazaud et al., 1996). neural crest origins of these mesenchymal cells. In addition,
the trigeminal ganglion is partly derived from neural crestNeural crest cells will form from the lateral edges of the
neural folds once the neural tube has formed (Selleck and cells and this ganglion expresses high levels of AP-2 in both
chick and mouse (Mitchell et al., 1991; Chazaud et al.,Bronner-Fraser, 1995) thus the AP-2 expressing region in-
cludes presumptive neural crest. However, at these early 1996).
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Down-regulation occurs in the maxillary and mandibu- we would see induction of AP-2. Our dose-response studies
showed that unilateral facial clefts are induced with lowerlar prominences after stage 20. The medial, caudal regions
of the maxillary prominences form the palatal shelves, doses therefore we expect that AP-2 would also be down-
regulated in these embryos (Richman and Leon Delgado,whereas the lateral regions form the quadrojugal and pter-
ygoid bones. AP-2 expression in the maxilla may be ne- 1995).
cessary for correct patterning of the bones. Decrease in
AP-2 expression in the mandibular prominences is more
The Retinoic Acid Defect in the Lateral Nasal andcomplete. The only region that retains high levels of ex-
Frontonasal Mass Is Correlated with Localizedpression is the auricular hillock which forms the external
Increases in Programmed Cell Deathear and a curious patch on the stomodeal side of the man-
dibular prominence. Timely down-regulation of AP-2 The extent of programmed cell death in the stage 24
may be necessary for patterning the mandibular skeletal chick face has been examined using Nile Blue Sulfate
elements. staining (Wedden, 1991; Mina et al., 1995; Barlow and
Francis-West, 1997). Several areas of increased staining
were noted in both normal and treated embryos and these
Retinoic Acid-Induced Clefting Is Correlated with correspond closely to our TUNEL data. Areas of corre-
Down-Regulation of AP-2 spondence include the junction of the lateral nasal and
maxillary prominence, the corners of the frontonasalWe have created a speci®c defect in the upper beak by
mass, and the caudal edge of the mandibular prominence.local application of retinoic acid to the nasal pit, long after
Programmed cell death also occurs in the cleft of theneural crest cell migration has ceased. The embryos have
mandible, at the caudal edge of the second branchial arch,decreased expression of AP-2 in the frontonasal mass and
and in the trigeminal ganglion.lateral nasal prominences, both regions known to be targets
Our study, however, differs from that of Wedden (1991)of retinoic acid (Tamarin et al., 1984; Wedden and Tickle,
in that we can detect a localized increase in cell death 24 hr1986; Wedden, 1987; Richman and Delgado, 1995; Rich-
after retinoic acid-bead implantation in both the epitheliumman, unpublished data). The maxillary and mandibular
and the mesenchyme. Increased numbers of dying cells areprominences are known to be unaffected by retinoic acid
observed adjacent to the nasal pit where the retinoic acidas determined by grafting individual prominences from em-
bead was implanted. The proportion of dying cells in thebryos treated with a high dose of retinoic acid (Wedden,
mesenchyme is small and is unlikely to account for the1987; Richman, unpublished results). The maxillary promi-
signi®cant decrease in AP-2 expression following retinoicnences normally fuse with the lateral nasal and frontonasal
acid treatment. In epithelial-mesenchymal recombinationmass prominences; however, retinoic acid exposure inhibits
studies the target of retinoic acid is known to be the mesen-outgrowth of the frontonasal mass thereby preventing fu-
chyme rather than the epithelium (Wedden, 1987). The cellsion from taking place. There are no changes in AP-2 expres-
death observed in the ectoderm following retinoic acidsion in the maxillary or mandibular prominences following
treatment is likely to be secondary to changes in the mesen-retinoic acid treatment, which is consistent with the lack
chyme.of response to retinoic acid.
The concentration of retinoic acid that the cells of the
face are exposed to is higher than that used to induce dupli- Retinoic Acid and AP-2 Transcription
cations of the limb bud but similar to that used to produce
truncations of the limb (Tickle et al., 1985). It is unlikely Are the effects of retinoic acid on AP-2 expression in the
face regulated via changes in gene transcription? Althoughthat if we used lower concentrations of retinoic acid that
FIG. 6. Retinoic acid down-regulates AP-2 expression. Embryos implanted with beads (arrowhead) soaked in DMSO (C, E), or 5 mg/ml
retinoic acid (B, D, F) placed in the right nasal pit at stage 20. All were hybridized with antisense probe for AP-2a. Scale bar, 0.5 mm.
Key: (b) bead, (fnm) frontal nasal mass, (ln) lateral nasal prominence, (mx) maxilla prominence, (md) mandibular prominence, (np) nasal
pit, (st) stage, (2) 2nd branchial arch. (A) Normal, untreated stage 22 embryo. Expression of AP-2 around the nasal pits. (B) Down-regulation
of AP-2 expression in the lateral nasal prominence and lateral edge of the frontonasal mass 8 hr after bead implantation in the right nasal
pit (arrowhead). (C) Stage 24 embryo treated with a DMSO-soaked bead. High levels of AP-2 expression are noted in the lateral nasal
process and frontonasal mass. Maxillary prominences express AP-2 at the lateral edges and inferior-medial edge. (D) Complete down-
regulation of AP-2 16 hr after bead implantation in the right nasal pit (arrowhead). (E) AP-2 expression is seen across the caudal edge of
the frontonasal mass 48 hr after a DMSO-soaked bead was implanted in the right nasal pit. There are also AP-2 transcripts in the lateral
nasal prominence (arrowheads) and lateral aspect of the maxillary prominences. (F) Forty-eight hours after retinoic acid bead implantation
there is signi®cant down-regulation of AP-2 expression in the lateral nasal prominence and right side of the frontonasal mass prominence
(arrowheads). There is no change in expression within the maxillary prominences.
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FIG. 7. Cell death in retinoic acid-treated embryos using the TUNEL method. Embryos in A, B, and D were treated with a retinoic acid-
soaked bead placed in the right nasal pit at stage 20. A and B were stained as wholemounts, whereas in C and D embryos were sectioned
®rst and then stained. Scale bar, 1 mm in A, B; 250 mm in C, D. Key: (b) bead, (fnm) frontal nasal mass, (ln) lateral nasal prominence,
(mx) maxilla prominence, (md) mandibular prominence, (np) nasal pit. (A) Twenty-four hours after retinoic acid bead implantation, punctate
staining indicating dying cells is evident around the nasal pit, the junction of the maxillary and lateral nasal prominences, the caudal
edge of the frontonasal mass, and the central cleft in the mandibular prominence (arrowheads). (B) A second embryo treated identically
to that in A. Similar areas of increased cell death around the right nasal pit are seen as in A (arrowheads). (C) Frontal section. Untreated
stage 24 embryo demonstrates a line of dying cells in the mesenchyme between the lateral nasal and the maxillary prominence. (D) Frontal
section. Forty-eight hours after retinoic acid bead implantation there is increased cell death in the mesenchyme and epithelium on the
right side of the frontonasal mass (arrowheads).
our experiments do not address this issue, there is evidence imply that the AP-2 induction is a secondary response to
activation of other genes and may be associated with cellin other experimental systems that retinoic acid can regu-
late AP-2 transcription. The expression of AP-2 is up-regu- differentiation. AP-g/2.2 expression in P19 embryonal car-
cinoma cells is increased 30 min following retinoic acidlated within 24 hr in teratocarcinomal cells treated with
retinoic acid (Williams et al., 1988; LuÈ scher et al., 1989). A treatment due to an increase in transcription rate (Oulad-
Abdelghani et al., 1996).similar increase in transcription was detected in embryonal
carcinoma cells of the neuroectodermal lineage but not in In the present study we clearly observed down-regulation
of AP-2 following retinoic acid treatment. Changes in AP-cells of the mesoendodermal lineage nor in cultures of pri-
mary astrocytes (Philipp et al., 1994). The up-regulation in 2 expression in facial cells treated with retinoic acid pre-
cedes any changes in morphology. One explanation for theboth cases is at the transcriptional level but the kinetics
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difference between our results and those observed in cell There is a binding site for AP-2 in the Msx-1 promoter
(Kuzuoka et al., 1994) although functional activation hasculture may be that we are not inducing cell differentiation
prior to changes in gene expression. Rather than being in- not been tested. The expression of Msx-1 was studied in
the transgenic AP-2a 0/0 embryos (Schorle et al., 1996).volved with cell differentiation in vivo, we hypothesize that
AP-2 down-regulation affects outgrowth of facial promi- Msx-1 transcripts were absent in the medionasal region
of 0/0 mice but were still present in the lateral nasal,nences. The 8-hr delay in AP-2 down-regulation observed
in retinoic acid-treated faces leaves open the possibility that maxillary, and mandibular prominences. The pattern of
expression was different compared to //0 littermates.other genes are activated before we see changes in AP-2
expression. Msx-1 was not restricted to the tips of the prominences
but was concentrated on the lateral aspects, as thoughIf AP-2 down-regulation in the face is not the primary
effect of exogenous retinoids, what genes might be up- the direction of growth of the facial prominences was
changed. This correlated with the midline cleft of thestream from AP-2? The sequence of the human (Bauer et
al., 1994) and chick AP-2 promoters has been studied facial bones in older embryos. It is possible that AP-
2a was required for establishing the pattern of Msx-1(Creaser et al., 1996) and no retinoic acid response ele-
ments (RAREs) have been identi®ed. However, there are transcripts in the facial prominences. The reason that
Msx-1 was not completely down-regulated in thefunctionally active AP-2 binding sites indicating that au-
toregulation can occur (Bauer et al., 1994). We cannot transgenic mice may be that other AP-2 genes also ex-
pressed in the face compensated for the lack of AP-2arule out the possibility that AP-2 genes are in¯uenced
by another gene upstream in the developmental pathway (AP-g/2.2; Chazaud et al., 1996).
that contains a RARE. We know that retinoic acid recep-
tors and cellular retinoic acid binding proteins are ex-
Lack of Response of the Mandibular Prominencespressed at high levels in the chick facial prominences
to Retinoic Acid May Be Due to a De®ciency in(Rowe et al., 1991, 1992; Smith and Eichele, 1991; Vaes-
AP-2 Transcriptssen et al., 1990; Maden et al., 1991) thus the door is left
open for gene interactions via RAREs. The basis for the lack of response of the mandibular prom-
inences to retinoic acid could be explained by the down-
regulation of AP-2 transcripts shortly after stage 20. Even
Msx-1 and Other Potential Downstream Target when a retinoic acid bead is placed in direct contact with
Genes of the AP-2 Transcription Factor the mandibular prominence there is no effect on morpho-
genesis or on Msx-1 expression (Brown et al., 1997). It isMsx-1 and Msx-2 are expressed in similar regions to
AP-2. In particular there is high expression of all three possible that embryos younger than stage 20 treated with
retinoic acid would have mandibular defects since expres-genes in the lateral nasal prominences and corners of the
frontonasal mass (Brown et al., 1996) as well as the distal sion in the ®rst branchial arch is pronounced from stage 14
to stage 20. We have found that embryos treated at youngermesenchyme of the limb bud (Davidson et al., 1991; Yo-
kouchi et al., 1991; Nohno et al., 1992; Mitchell et al., stages have pronounced defects in Meckel's cartilage and
other hypobranchial structures (Saurette and Richman, un-1989; Chazaud et al., 1996). Pronounced down-regula-
tion of Msx-1 and Msx-2 expression was observed in the published results).
lateral nasal prominences following exposure to exoge-
nous retinoic acid at stage 20 (Brown et al., 1996) and
AP-2 and Limb Outgrowthsimilarly, Msx-1 was down-regulated in the limb bud
following retinoic acid bead implantation (Yokouchi et AP-2 is one of several signals in the limb that are asso-
ciated with outgrowth. The lack of outgrowth in limbal., 1991). In contrast, the frontonasal mass often re-
tained expression of both genes up to 48 hr following buds stripped of their AER is strongly correlated to down-
regulation of AP-2 just as truncation of the upper beakbead implantation. Our results show that AP-2 expres-
sion was nearly absent from the right side of the fron- by retinoic acid is associated with a down-regulation of
AP-2. The time course of down-regulation is very similartonasal mass in addition to the lateral nasal prominence
16 hr following bead implantation. Thus AP-2 expres- to that documented for Cek-8 (chicken embryo kinase-
8; Patel et al., 1996). The changes in gene expressionsion in the frontonasal mass appears to be more respon-
sive to retinoic acid than does Msx-1. Two possible ex- precede major changes in the size of the limb bud and the
timing of down-regulation is identical to that observed inplanations should be considered. The ®rst is that Msx-
1 responds directly to retinoic acid via a cis-regulatory the retinoic acid-treated face. We have also demonstrated
that AP-2 expression in distal limb bud mesenchyme canelement that has been identi®ed in the promoter (Shen
et al., 1994). Therefore, the timing of response of the be maintained by FGFs as are Msx-1 (Vogel et al., 1995)
and Cek-8 (Patel et al., 1996). Other genes expressed inMsx-1 gene in relation to the AP-2 gene in retinoic acid-
treated embryos may be coincidental. the progress zone of the limb (Summerbell et al., 1973)
may be involved in the regulation of AP-2 expression andThe second possibility is that AP-2 regulates Msx-1.
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FIG. 8. AP-2 expression in limb buds is associated with distal outgrowth. All embryos hybridized to an antisense probe for chick AP-2a. A
is a sagittal view, B is a ventral view, and C±F are dorsal views of the embryo. Scale bar equals 1 mm for A, B; 0.5 mm for C±G. Key: (aer)
apical ectoderm ridge, (ah) auricular hillock, (b) bead, (md) mandibular prominence, (mx) maxillary prominence, (2) second branchial arch. (A)
Stage 24. Expression in the distal (arrow with tail) and anterior mesenchyme of limb buds (arrowheads), the caudal edge of the second branchial
arch, the auricular hillock, the caudal edge of the maxillary prominence, and the dorsal root ganglia. (B) Stage 24. Additional expression domains
are seen on the ventral side of the leg buds. (C) Stage 24. Right limb has had the AER removed at stage 20, a bead soaked in FGF-4 was stapled
to the apex of the wing bud and the embryo was incubated for 24 hr. There are high levels of AP-2 transcripts surrounding the bead. The left
wing bud has not been manipulated and the AER is devoid of AP-2 transcripts. (D) Stage 21. Four hours since AER removal, there is partial
down-regulation of AP-2 in the mesenchyme. (E) Stage 21. Six hours since AER removal, AP-2 expression is slightly above background levels
in the right limb bud. (F) Stage 22. Eight hours since ridge removal, there is complete down-regulation of AP-2 in the right limb bud. (G) Stage
22.5. Twelve hours since ridge removal, AP-2 transcripts are completely absent in the right limb bud. The right limb bud is noticeably smaller
than the left limb bud. The left limb bud was injured during in situ hybridization.
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these molecular relationships will need to be investi- grammed cell death at the dorsal edges of the neural folds
in 0/0 embryos. Thus it is possible that there is a selec-gated in more detail.
The effects of disrupting AP-2a in transgenic mice on tive loss of neural crest cells that contribute to the facial
mesenchyme, a loss that may not be detected with anti-limb development were relatively mild. Null-mutant
embryos displayed forelimb phocomelia (the radius was body staining. Finally, it is possible that the speci®ca-
tion of neural crest cells (as in Noden, 1983) be could beabsent in 18 of 28 0/0 fetuses; Zhang et al., 1996). On
a different genetic background the AP-2 0/0 mice have disrupted in AP-2 0/0 mice, a hypothesis that remains
to be tested.general retardation of the development as well as loss
of the radius (P. J. Mitchell, personal communication).
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